Rhamnolipids---brief outline
============================

Biosurfactants, widely known as surface-active agents of biological origin, have carved a niche for themselves in the market due to their unique environment-friendly properties. They have come a long way since first biosurfactant "surfactin" was purified and characterized by Arima et al. ([@B2]). Biosurfactants have been researched thoroughly and satisfactorily since then by many research groups across the world yet there are aspects that elude our understanding. There are five major categories of biosurfactants viz. glycolipids, phospholipids and fatty acids, lipopeptides and lipoproteins, polymeric biosurfactants and particulate biosurfactants that have found applications in agricultural, pharmaceutical, food, cosmetics, and detergent industries. Data reveals there are more than 250 patents obtained on these wonder biodegradable molecules so far (Shete et al., [@B16]; Rahman and Gakpe, [@B12]). It has also been observed that microbial biosurfactants are advantageous over plant-based surfactants because of the scale-up capacity, rapid production, and multi-functional properties. Several plant-based biosurfactants for example saponins, lecithins, and soy proteins have excellent emulsification properties but are expensive to produce at industrial scale and have other debatable issues such as solubility and hydrophobicity (Xu et al., [@B19]).

Among the various categories of biosurfactants the glycolipid biosurfactants "rhamnolipids" stand apart. Rhamnolipid, primarily a crystalline acid, is composed of β-hydroxy fatty acid connected by the carboxyl end to a rhamnose sugar molecule. Rhamnolipids are predominantly produced by *Pseudomonas aeruginosa* and classified as: mono and di-rhamnolipids. Other *Pseudomonas* species that have been reported to produce rhamnolipids are *P. chlororaphis*, *P. plantarii, P. putida*, and *P. fluorescens*. Some bacteria are known to produce only mono-rhamnolipids while some produce both. The ratio of mono and di-rhamnolipid can also be controlled in the production method. There are enzymes available that can convert mono-rhamnolipids into di-rhamnolipids. In 1984, the first patent for the production of rhamnolipids was filed by Kaeppeli and Guerra-Santos (US 4628030) and obtained in 1986 for their work on *Pseudomonas aeruginosa* DSM 2659 (Kaeppeli and Guerra-Santos, [@B6]). Subsequently, Wagner et al. filed a patent (US 4814272) in 1985 for the biotechnical production of rhamnolipids from *Pseudomonas sp*. DSM 2874 and obtained the same in 1989 (Wagner et al., [@B18]). In the past close to three decades, there has been a great body of research work carried on rhamnolipids revealing many of their astonishing applications and making them reach the pinnacle of popularity among all the categories of biosurfactants in the global market. The reason behind the current global interest in rhamnolipid production owes to their broad range of applications in various industries along with many spectacular "eco-friendly" properties.

The current critique articulates to present opinion on rhamnolipid research and is an attempt to retrospect what brings rhamnolipids in the forefront. This article is a bird\'s-eye view on a timeline of rhamnolipids story so far and also a critical analysis on why despite so many patents and research work rhamnolipids still do not rule the global biosurfactant market.

Inimitable applications of rhamnolipids
=======================================

Over the years rhamnolipids are becoming broadly pertinent in various industries and are posing a serious threat to the synthetic surfactants. Before venturing into the current production economics of rhamnolipids it is imperative to evaluate the major applications of rhamnolipids that make them noticeable among other biosurfactants. A list of five major applications of rhamnolipids that cater to the wide range of industrial demands includes:

1.  *Bioremediation and enhanced oil recovery (EOR)*: Rhamnolipids show excellent emulsification properties, efficiently remove crude oil from contaminated soil and facilitate bioremediation of oil spills (Rahman et al., [@B10]; Costa et al., [@B5]).

2.  *Pharmaceuticals and therapeutics*: Rhamnolipids show low toxicity, surface active properties and antimicrobial activities against several microbes (*Bacillus cereus, Micrococcus luteus, Staphylococcus aureus, Listeria monocytogenes*) thereby showing promising applications in pharmaceuticals and therapeutics (Magalhaes and Nitschke, [@B7]).

3.  *Cosmetics*: Rhamnolipid as an active ingredient is found to be effective for several skin treatments i.e., wound healing with reduced fibrosis, cure of burn shock, treatment of wrinkles hence are in demand in the health and beauty industry (Piljac and Piljac, [@B9]).

4.  *Detergents and cleaners*: Rhamnolipids are natural emulsifiers and surface active agents leading to their wide spread usage in detergent compositions, laundry products, shampoos and soaps (Parry et al., [@B8]).

5.  *Agriculture*: Rhamnolipids are already used for soil remediation for improving soil quality and are now further getting explored for plant pathogen elimination, for aiding the absorption of fertilizers and nutrients through roots and as biopesticides (Sachdev and Cameotra, [@B13]).

Biosurfactant producing companies---with focus on rhamnolipids
==============================================================

Rhamnolipids are highly applicable in various activities with some researchers advancing the technology from laboratory to higher scale. However, there still are very limited companies in the field which are producing biosurfactants at a marketable scale. We tried to compile a list of biosurfactant producing companies around the globe (Table [1](#T1){ref-type="table"}). The compilation evidently defines which biosurfactants are mostly researched and produced at higher scale.

###### 

**Biosurfactant producing companies around the globe**.

  **S. No**.   **Company**                         **Location(s)**       **Product(s)**                                                                                                                                      **Focus on**
  ------------ ----------------------------------- --------------------- --------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------
  1            TeeGene Biotech                     UK                    Rhamnolipids and Lipopeptides                                                                                                                       Pharmaceuticals, cosmetics, antimicrobials and anti-cancer ingredients
  2            AGAE Technologies LLC               USA                   Rhamnolipids (R95, an HPLC/MS grade rhamnolipid)                                                                                                    Pharmaceutical, cosmeceutical, cosmetics, personal care, bioremediation (*in situ* & *ex situ*), Enhanced oil recovery (EOR)
  3            Jeneil Biosurfactant Co. LLC        USA                   Rhamnolipids (ZONIX, a bio-fungicide and RECO, a rhamnolipid used in cleaning and recovering oil from storage tanks)                                Cleaning products, EOR
  4            Paradigm Biomedical Inc.            USA                   Rhamnolipids                                                                                                                                        Pharmaceutical applications
  5            Rhamnolipid Companies, Inc.         USA                   Rhamnolipids                                                                                                                                        Agriculture, cosmetics, EOR, bioremediation, food products, pharmaceutical
  6            Fraunhofer IGB                      Germany               Glycolipids, Cellobiose lipids, MELs                                                                                                                Cleansing products, shower gels, shampoos, washing-up liquids, pharmaceutical (bioactive properties)
  7            Cognis Care Chemicals               China, Germany, USA   Alkyl polyglucoside APG^®^, Plantacare 1200 GLY (green surfactant for use in oral-dental formulations), Rheocare TTA (for cleansing formulations)   Used in formulations for household cleaners, bath/shower gels, dish washing, laundry detergents and in agrochemicals
  8            Saraya Co. Ltd.                     Japan                 Sophorolipids (Sophoron, a low-foam dishwasher detergent)                                                                                           Cleaning products, hygiene products
  9            Ecover Belgium                      Belgium               Sophorolipids                                                                                                                                       Cleaning products, cosmetics, bioremediation, pest control, pharmaceuticals
  10           Groupe Soliance                     France                Sophorolipids                                                                                                                                       Cosmetics
  11           MG Intobio Co. Ltd.                 South Korea           Sophorolipids (Sopholine---functional soap with Sophorolipids secreted by yeasts)                                                                   Beauty and personal care, bath supplies e.g., soaps with new functions
  12           Synthezyme LLC                      USA                   Sophorolipids                                                                                                                                       Cleaning products, cosmetics, food products, fungicides, crude oil emulsification
  13           Allied Carbon Solutions (ACS) Ltd   Japan                 Sophorolipids (ACS-Sophor---first bio-based surfactant from Indian mahua oil)                                                                       Agricultural products, ecological research
  14           Henkel                              Germany               Sophorolipids, Rhamnolipids, Mammoslyerthritol lipids                                                                                               Glass cleaning products, laundry, beauty products
  15           Lion Corporation                    Japan                 Methyl ester sulfonates (MES)                                                                                                                       Detergents formulations, cleaning products
  16           Lipo Chemicals                      USA                   Lipomulse Luxe (high-temperature resistance emulsifier)                                                                                             Skin care, sun-lotions hair care formulations, thickening polymers, rheological modifiers, natural gums
  17           Kaneka Co.                          Japan                 Sophorose lipids                                                                                                                                    Cosmetics and toiletry products

Availability of feedstock and its impact on biosurfactants
==========================================================

Biodiesel is produced by the trans-esterification of vegetable oils and fats with methanol in the presence of a catalyst. Glycerol is received as a by-product from this reaction. The production of 1 ton biodiesel generates about 100 kg of glycerol. Hence, the European biodiesel industry might release about 600 Kiloton glycerol per year with an increasing tendency in Europe and worldwide. Oversupply of glycerol, essentially due to increasing biodiesel production, leads to decreasing prices and weak markets.

The price of pure glycerol varied from \$0.50 to \$1.50/lb and crude glycerol from \$0.04/kg to \$0.33/kg over the past few years. The price of glycerol in the market will continue to drop in such an over saturated market. Currently, the main supply of glycerol coming into the market is from the rapidly growing biodiesel industry. Estimated production of glycerol would reach 5.8 billion pounds in 2020. This is due to demand of biodiesel that is projected at 8 billion gallons in 2020 (Ayoub and Abdullah, [@B3]). Hence new outlets for glycerol are urgently needed, particularly in the case of crude glycerol released by the biodiesel processes. As glycerol is a nontoxic, edible, biodegradable compound, it will provide important environmental benefits to the new platform products.

In case of biosurfactant production, dramatically rising in biodegradable, non-toxic and eco-friendly alternative for chemical surfactants and the re-discovered opportunity of biosurfactants that gave rise to invention and investment ahead of the typical rigors of techno-economic modeling for the use of glycerol as a feed stock, leading typically to unmet expectations. Bacteria produce biosurfactants if grown on carbon sources such as glucose, glycerol, and various vegetable oils. Our research on biosurfactant production by bacteria indicates that glycerol can be used efficiently for biosurfactant production (Rahman et al., [@B11]).

The considerable interest in biosurfactants in the recent years is also due to their low toxicity, biodegradable nature and specificity, which would be very suitable to meet the European Surfactant Directive. Regulation EC No.: 648/2004 requires clear and precise description of the biodegradability of the surfactant and test methods to give assurance of its aerobic biodegradability. This regulation establishes rules designed to achieve the free movement of detergents and surfactants for detergents in the internal market while, at the same time, ensuring a high degree of protection of the environment and human health.

Surfactants constitute an important class of industrial chemicals and are widely used in almost every sector of modern industry. Most of the commercially available surfactants are chemical surfactants mainly, petroleum-derived. However, rapid advances in biotechnology and increased environmental awareness among consumers combined with expected new environmental legislation has provided further impetus for serious consideration of biological surfactants as possible alternatives to existing products.

Biosurfactant\'s economic feasibility---what it takes to become a market leader?
================================================================================

As described in the previous section, there is enormous awareness among the consumers these days with regard to sustainability and global warming. The demand for bio-based technologies is ever increasing and "green solutions" are sought for every process. Rhamnolipids have promising properties and fulfill the eco-friendly criteria, one of the main drivers, but are still struggling to become market leaders. The economics of production is a major bottleneck in the outburst of commercialization of rhamnolipids and other biosurfactants (Table [2](#T2){ref-type="table"}). There is still no downstream technology economical and convincing enough to recover and purify rhamnolipids at industrial scale. In case of biosurfactant production the downstream processing accounts for 70--80% of the entire production costs.

###### 

**Cost of biosurfactant per liter of solution (diluted and the CMC based cost calculation carried out by Connolly et al., [@B4])**.

  **Biosurfactant**   **Origin**              **Supplier**                       **ST mN/m**   **CMC (%)**   **Cost (£/L)**
  ------------------- ----------------------- ---------------------------------- ------------- ------------- ----------------
  BioFuture           Bacterial rhamnolipid   BioFuture Ltd. Dublin              28            0.08          0.02
  Citrasolv           Orange peel             Cleveland Biotech Ltd., Teesside   30            0.9           0.01
  EC601               Bacterial rhamnolipid   Ecochem Ltd., Canada               29            0.2           0.23
  EC1800              Bacterial consortium    Ecochem Ltd., Canada               28            0.04          0.01
  Petrosolv           Bacterial unknown       Enzyme Technologies Inc., USA      34            0.2           0.01
  Saponin             Plant bark              Sigma UK                           45            0.1           0.50

*The table also gives the origin of biosurfactant along with surface tension (ST) and critical micelle concentration (CMC) values*.

It is a no-brainer that in order to gain higher profit at commercial scale it requires access to very cheap feedstock. There are some other key parameters that need thorough consideration in order to make any product economically feasible. Technological fit and process optimization are among the main drivers. Fermentation time is another key to success. Fermentation performance and scale impact process economy as it is directly related to the yield, titer, and productivity. High cost of production especially because of the expensive substrates and down-stream processes makes it difficult to bring down the price of these environment friendly biomolecules. In order to compete with the synthetic detergents or surfactants the cost of production must be brought down to £1.70 per liter which is in itself a challenging task. As there are many barriers in the commercialization of biosurfactants, there seems no dearth of opportunities in this field. Cost comparison of various technologies viz. enzymatic, continuous, shake flask, batch, and fed-batch used for biosurfactant production pinpoint the requirement of innovative methods wherein rhamnolipids can be produced in static conditions to reduce the fermentation cost. The operating costs can be brought down by robust wild-type strains or recombinant mutant strains. Testing the possibility of co-products and/or enzymes is another attractive solution to surge the net profit---for example: esterases released during the production of lipopeptides by *Bacillus* strain and its recombinants (Sekhon et al., [@B14], [@B15]). Co-products and by-products are value drivers and increase the economic viability of any business. The search of cheap and easily accessible raw material or substrate for biosurfactants production has been going on for years. The utilization of by-products, even if from a different process could be another smart solution---for example: glycerol, which is a by-product of biodiesel production, is available in surplus amount in the global market (Albarelli et al., [@B1]) which might be a cheap alternative for biosurfactant production.

Rhamnolipids are well-characterized and scientifically proven biosurfactants which are slowly and steadily becoming highly sought after biomolecules. Among other biosurfactants rhamnolipids have the highest number of patents (Table [3](#T3){ref-type="table"}) and research publications. However, cost-competitiveness is one of the major factors that is holding rhamnolipids back from becoming the champions of their field. Research needs to be focused on suitable vigorous production strains, cheap substrates and nominal bioreactor technology. The current market price of rhamnolipid (R-95, 95%) is \$227/10 mg (Sigma-aldrich) and \$200/10 mg (AGAE technologies, USA) calling for strenuous research. Rhamnolipids have favorable applications in various sectors and if made economically sustainable nothing can stop these biomolecules to rule the surface-active compounds market.

###### 

**A timeline and the major patents and grants obtained on rhamnolipids so far**.

  **S. No**.   **Patent or Application No**.   **Filed**    **Issued**   **Title**                                                                                                                                                             **Inventors**
  ------------ ------------------------------- ------------ ------------ --------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------
  1            4628030                         Aug 1984     Dec 1986     Process for the production of rhamnolipids                                                                                                                            Kaeppeli and Guerra-Santos
  2            4814272                         Feb 1985     March 1989   Process for the biotechnical production of rhamnolipids including rhamnolipids with only one. Beta.-hydroxydecanoic acid residue in the molecule                      Wagner et al.
  3            4933281                         March 1987   June 1990    Method for producing rhamnose                                                                                                                                         Daniels et al.
  4            4902512                         Jan 1988     Feb 1990     Rhamnolipid liposomes                                                                                                                                                 Ishigami et al.
  5            5417879                         Sep 1993     May 1995     Synergistic dual-surfactant detergent composition containing sophoroselipid                                                                                           Hall et al.
  6            5455232                         April 1994   Oct 1995     Pharmaceutical preparation based on rhamnolipid                                                                                                                       Piljac and Piljac
  7            5550227                         May 1994     Aug 1996     Method for the preparation of rhamnose monohydrate from rhamnolipids                                                                                                  Mixich et al.
  8            5466675                         July 1994    Nov 1995     Immunological activity of rhamnolipids                                                                                                                                Piljac and Piljac
  9            5520839                         Jan 1995     May 1996     Laundry detergent composition containing synergistic combination of sophorose lipid and non-ionic surfactant                                                          Hall et al.
  10           5501966                         Jan 1995     March 1996   *Pseudomonas aeruginosa* and its use in a process for the biotechnological preparation of L-rhamnose                                                                  Giani et al.
  11           5658793                         June 1995    Aug 1997     *Pseudomonas aeruginosa* and its use in a process for the biotechnological preparation of L-rhamnose                                                                  Giani et al.
  12           5514661                         Aug 1995     May 1996     Immunological activity of rhamnolipids                                                                                                                                Piljac and Piljac
  13           5767090                         Jan 1996     June 1998    Microbially produced rhamnolipids (biosurfactants) for the control of plant pathogenic zoosporic fungi                                                                Stanghellini et al.
  14           7129218                         Aug 2000     Oct 2006     Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration                                                            Stipcevic et al.
  15           7262171                         Aug 2000     Aug 2007     Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics                                Piljac and Piljac
  16           20040224905                     May 2002     Nov 2004     Use of rhamnolipids in wound healing, treatment and prevention of gum disease and periodontal regeneration                                                            Stipcevic et al.
  17           20060233935                     Nov 2003     Oct 2006     Rhamnolipids in bakery products                                                                                                                                       Haesendonck and Vanzeveren
  18           7202063                         Aug 2005     April 2007   Processes for the production of rhamnolipids                                                                                                                          Gunther et al.
  19           20070191292                     Feb 2006     Aug 2007     Antimycotic rhamnolipid compositions and related methods of use                                                                                                       Gandhi et al.
  20           20070155678                     Feb 2007     July 2007    Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics                                Piljac and Piljac
  21           20070207930                     Feb 2007     Sep 2007     Rhamnolipid compositions and related methods of use                                                                                                                   Gandhi et al.
  22           7968499                         Feb 2007     June 2011    Rhamnolipid compositions and related methods of use                                                                                                                   Gandhi and Skebba
  23           20080213194                     July 2007    Sep 2008     Rhamnolipid-based formulations                                                                                                                                        Keith DeSanto
  24           7985722                         July 2007    July 2011    Rhamnolipid-based formulations                                                                                                                                        Keith DeSanto
  25           20100249058                     Oct 2007     Sep 2010     Feed additive and feed                                                                                                                                                Ito et al.
  26           20090126948                     Nov 2007     May 2009     Use of rhamnolipid based formulations for fire suppression and chemical and biological hazards                                                                        Keith DeSanto
  27           20080261891                     Feb 2008     Oct 2008     Compositions and methods for using syringopeptin 25A and rhamnolipids                                                                                                 Bart C. Weimer
  28           20090220603                     May 2009     Sep 2009     Use of rhamnolipids in wound healing, treating burn shock, atherosclerosis, organ transplants, depression, schizophrenia and cosmetics                                Piljac and Piljac
  29           20110123623                     Nov 2010     May 2011     Rhamnolipid mechanism                                                                                                                                                 Keith DeSanto
  30           20120322751                     Feb 2011     Dec 2012     Use of rhamnolipids as a drug of choice in the case of nuclear disasters in the treatment of the combination radiation injuries and illnesses in humans and animals   Goran Piljac
  31           20110257115                     June 2011    Oct 2011     Method for treating rhinitis and sinusitis by rhamnolipids                                                                                                            Anton Leighton
  32           20110306569                     June 2011    Dec 2011     Rhamnolipid biosurfactant from *Pseudomonas aeruginosa* strain NY3 and methods of use                                                                                 Yin et al.
  33           8592381                         June 2011    Nov 2013     Method for treating rhinitis and sinusitis by rhamnolipids                                                                                                            Anton Leighton
  34           20110270207                     July 2011    Nov 2011     Rhamnolipid based formulations                                                                                                                                        Keith DeSanto
  35           8183198                         July 2011    May 2012     Rhamnolipid-based formulations                                                                                                                                        Keith DeSanto
  36           20130130319                     July 2011    May 2013     Cells and methods for producing rhamnolipids                                                                                                                          Schaffer et al.
  37           20120255918                     April 2012   Oct 2012     Use of rhamnolipids in the water treatment industry                                                                                                                   DeSanto and Keer
  38           20130296461                     May 2013     Nov 2013     Aqueous coatings and paints incorporating one or more antimicrobial biosurfactants and methods for using same                                                         Lakshmi Sadasivan
  39           20130310330                     July 2013    Nov 2013     Method for treating obesity                                                                                                                                           Anton Leighton
  40           8765694                         July 2013    July 2014    Method for treating obesity                                                                                                                                           Anton Leighton
  41           20140080771                     Nov 2013     March 2014   Method for treating rhinitis and sinusitis by rhamnolipids                                                                                                            Anton Leighton
  42           20140148588                     Nov 2013     May 2014     Process for the isolation of rhamnolipids                                                                                                                             Schilling et al.

Concluding remarks
==================

As the Health and Safety in the bioprocessing become paramount for large scale production there are significant interests in the search for novel non-pathogenic rhamnolipid producers. The numbers of cultured organisms from the environmental samples are only a tiny fraction (0.001%) of the actual microbial diversity. There are significant number of microbial isolates that needs to be explored and exploited for rhamnolipid and other bioproduct manufacturing. Biosurfactant producing probiotic organisms will play a key role in the future of biosurfactant market. Edible emulsifiers from these processes would be applicable to many applications including food, cosmetic, environmental clean-up, biomedical and natural therapy. Rhamnolipid could be a potential alternative for the synthetic surfactant molecules and an important platform chemical cluster with the market value of \$2.8 billion in 2023 (Grand View Research Inc., [@B17]). There is a significant need for the discovery of novel non-pathogenic rhamnolipid producers with enhanced production capacity and efforts to scale up through bioprocess engineering are important to meet the future predictions of biosurfactants market.
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